Pet Flea Treatment Class Action — Risk of Chemical Burns, Seizure, and Central Nervous System Side Effects

The Wall Street Journal today is reporting new data compiled by the U.S. Environmental Protection Agency (EPA), concerning a significant increase in the number of “incidents stemming from so-called spot-on flea and tick treatments.” According to the latest statistics, the number of adverse incidents involving pets and the use of such treatments “increased 53% to 44,263 in 2008 from the previous year.” Thus, the EPA is “intensifying an evaluation of spot-on products.”

Furthermore, according to the article, the list of products in questions includes “major manufacturers such as Sumitomo Corp.’s Hartz Mountain Corp., Central Life Sciences, Bayer AG, maker of Advantage, and Merial Ltd., a joint venture between Merck & Co. and Sanofi-Aventis SA, that makes Frontline products.”

Such pet side effects from the use of such products may include chemical burns to a pet’s skin, seizures, central nervous system side effects, and dangerous anemia related conditions. If you or someone you know is a pet owner and has suffered a spot-on flea and tick treatment related side effect, please contact our law firm immediately for a free consultation.